M MC1 (Mycophenolic acid delayed-release 180 mg)

Pill imprint M MC1 has been identified as Mycophenolic acid delayed-release 180 mg.

Mycophenolic acid is used in the treatment of rejection prophylaxis; dermatomyositis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolic acid 180 mg is not a controlled substance under the Controlled Substance Act (CSA).

Mycophenolic acid delayed-release

Imprint:

M MC1

Strength:

180 mg

Color:

Green

Shape:

Round

Availability:

Prescription only

Drug Class:

Selective immunosuppressants

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.